Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Acquisition

11 Apr 2017 15:30

RNS Number : 2115C
Exova Group PLC
11 April 2017
Β 

Β 

STOCK EXCHANGE RELEASE

Β 

11 April 2017

Exova Group plc

Β 

Exova acquires SL Pharma Labs Incorporated

Β 

Exova Group plc ("Exova") EXO.L, the global testing, calibration and advisory services provider, has acquired SL Pharma Labs Incorporated (SL Pharma), a Delaware, US, based business that provides laboratory and clinical manufacture testing services to pharmaceutical, biotechnology and medical device companies.

Founded in 1997, SL Pharma has built a strong reputation in the provision of high value and high quality pharmaceutical product development and testing services focused primarily on the development and clinical manufacture of parenteral, ophthalmic, intranasal and topical drug products. The business has a team of 14 specialists and achieved revenues of around $2.5m in 2016.

Ian El-Mokadem, Chief Executive Officer at Exova, said: "This acquisition complements our existing operations by enhancing Exova's technical expertise in pharmaceutical services and offers a great foundation for further growth in North America. SL Pharma's addition to our portfolio clearly demonstrates our commitment to providing more technically demanding services and developing our capabilities in new markets."

Β 

ENDS

Β 

Β 

Enquiries:

Β 

Andy Jones

Powerscourt

T: +44 (0) 20 7549 0747

E: andy.jones@exova.com

Β 

Andrew Pickup

Corporate Affairs Director, Exova Group plc

T: +44 (0) 7920 243 393

E: andrew.pickup@exova.com

Exova

Β 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 135 laboratories and offices in 33 countries and employs around 4,200 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Transportation; and Health Sciences.

Exova Group plc is registered in England (registration number 08907086). Its legal entity identifier ('LEI') number is 213800BFE317FGSYMZ19.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQBBGDSSGBBGRB
Date   Source Headline
12th Jun 201710:17 amRNSForm 8.5 (EPT/RI)
12th Jun 201710:01 amRNSForm 8.3 - EXOVA GROUP PLC
12th Jun 20179:42 amRNSForm 8.5 (EPT/RI)
9th Jun 20174:41 pmRNSForm 8.5 (EPT/RI) - Replacement
9th Jun 20171:26 pmRNSResults of the Court Meeting and General Meeting
9th Jun 20171:08 pmRNSForm 8.3 - EXOVA GROUP PLC
9th Jun 201710:41 amRNSForm 8.5 (EPT/RI)
8th Jun 201710:07 amRNSForm 8.5 (EPT/RI)
8th Jun 20179:57 amRNSForm 8.3 - EXOVA GROUP PLC
7th Jun 20173:50 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jun 201711:56 amRNSForm 8.5 (EPT/RI)
7th Jun 201710:46 amRNSForm 8.3 - EXOVA GROUP PLC
7th Jun 201710:37 amRNSForm 8.5 (EPT/RI)
6th Jun 20173:30 pmRNSForm 8.3 - EXO LN
6th Jun 20173:25 pmBUSForm 8.3 - Exova Group PLC
6th Jun 20171:46 pmRNSForm 8.3 - Exova Group PLC
6th Jun 201710:56 amRNSForm 8.3 - EXOVA GROUP PLC
6th Jun 201710:47 amRNSForm 8.5 (EPT/RI)
6th Jun 201710:21 amRNSForm 8.3 - EXOVA GROUP PLC
5th Jun 201711:43 amRNSForm 8.5 (EPT/RI)
5th Jun 201710:57 amRNSForm 8.5 (EPT/RI)
5th Jun 20177:00 amRNSRecommended Acquisition of Exova Regulatory Update
2nd Jun 20171:22 pmRNSForm 8.3 - Exova Group PLC
2nd Jun 201711:06 amRNSForm 8.5 (EPT/RI)
2nd Jun 201711:04 amRNSForm 8.3 - EXOVA GROUP PLC
2nd Jun 201711:00 amRNSForm 8.5 (EPT/RI)
1st Jun 20171:31 pmRNSForm 8.3 - Exova Group Plc
1st Jun 201712:44 pmRNSTR-1: Notification of Major Interest in Shares
1st Jun 201710:47 amRNSForm 8.3 - Exova Group PLC
1st Jun 201710:47 amRNSForm 8.5 (EPT/RI)
31st May 201711:46 amRNSForm 8.3 - Exova Group Plc
31st May 201710:54 amRNSForm 8.5 (EPT/RI)
31st May 201710:48 amRNSForm 8.3 - EXOVA GROUP PLC
31st May 201710:44 amRNSForm 8.5 (EPT/RI)
30th May 20173:03 pmRNSForm 8.5 (EPT/RI) - Amendment
30th May 20172:00 pmBUSForm 8.3 - Exova Group Plc
30th May 20179:51 amRNSTR-1: Notification of Major Interest in Shares
30th May 20177:00 amRNSForm 8.3 - EXO LN
30th May 20177:00 amRNSForm 8.3 - EXOVA GROUP PLC
30th May 20177:00 amRNSForm 8.3 - EXOVA GROUP PLC
30th May 20177:00 amRNSForm 8.3 - EXOVA GROUP PLC
30th May 20177:00 amRNSForm 8.3 - Exova Group Plc
30th May 20177:00 amRNSForm 8.5 (EPT/RI)
26th May 20175:19 pmRNSRule 2.8 announcement
26th May 20174:24 pmRNSForm 8.5 (EPT/RI) - Amendment
26th May 201711:53 amRNSForm 8.5 (EPT/RI)
26th May 201710:27 amRNSForm 8.5 (EPT/RI)
26th May 201710:22 amRNSForm 8.3 - EXOVA GROUP PLC
25th May 201710:55 amRNSForm 8.5 (EPT/RI)
24th May 20173:18 pmRNSForm 8.3 - Exova Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.